Azithromycin (Azithro)

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Ladoke Akintola University of Technology, Ogbomoso, Nigeria, Alexa Henderson

Conditions

COVID-19PPROMPreterm Prelabor Rupture of MembranesRheumatic FeverSARS-CoV 2Valvular CardiomyopathyValvular Heart Diseases

Phase 2

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

TerminatedNCT04358068

National Institute of Allergy and Infectious Diseases (NIAID)COVID-19, SARS-CoV 2

Start: 2020-05-13End: 2020-07-08Updated: 2021-11-16

Phase 4

Extended Azithromycin Treatment in Prelabor Rupture of Membranes

Not yet recruitingNCT07669207

Alexa HendersonPPROM, Preterm Prelabor Rupture of Membranes

Start: 2026-07-01End: 2028-07-01Target: 30Updated: 2026-06-25

Unknown Phase

Improving Management and Secondary Prevention Through Azithromycin Comparative Trial in Rheumatic Heart Disease in Nigeria)- IMPACT-RHD Nigeria

Not yet recruitingNCT07625228

Ladoke Akintola University of Technology, Ogbomoso, NigeriaRheumatic Fever, Valvular Cardiomyopathy, Valvular Heart Diseases

Start: 2027-01-05End: 2031-12-30Target: 474Updated: 2026-06-04